Performance of prostate multiparametric MRI for prediction of prostate cancer extra-prostatic extension according to NCCN risk categories: implication for surgical planning
Ugo Giovanni Falagario(Ospedali Riuniti di Foggia), Ashutosh Tewari(Icahn School of Medicine at Mount Sinai), Ethan Wajswol(Icahn School of Medicine at Mount Sinai), Deron Phillip(Icahn School of Medicine at Mount Sinai), Luigi Cormio(University of Foggia), George Papastefanou(Icahn School of Medicine at Mount Sinai), Alberto Martini(The University of Texas MD Anderson Cancer Center), Anna Lantz(Mount Sinai Hospital), Ivan Jambor(University of Turku), Patrick‐Julien Treacy(Mount Sinai Hospital), Parita Ratnani(Mount Sinai Hospital), Sara Lewis(Icahn School of Medicine at Mount Sinai), Rachel Weil(Icahn School of Medicine at Mount Sinai), Natasha Kyprianou(Icahn School of Medicine at Mount Sinai), Giuseppe Carrieri(University of Foggia), Kenneth Haines(Mount Sinai Hospital), Peter Wiklund(Unknown)
Cited by 27
Related Papers
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines
|European Urology|2023|656
Tubulin-Targeting Chemotherapy Impairs Androgen Receptor Activity in Prostate Cancer
|Cancer Research|2010|350
Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease
|Annals of the Rheumatic Diseases|2001|287